Sanofi defends Garijo appointment, says it is 'fully committed' to immunology

Sanofi’s first-quarter earnings call with the media on Thursday was an exercise in redirecting the narrative before its new CEO steps in next week. CFO François-Xavier Roger defended the company’s appointment of Merck KGaA’s Belén ...